Musculoskeletal Diseases Treatment Market to reach $ 5,730.8 Mn in 2025: Alltech Medical Systems, General Electric, Koninklijke Philips, Siemens, Hitachi, Accuray Incorporated, and MR Solutions

The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 and is growing at a CAGR of 5.3% from 2018-2025.

The market for musculoskeletal diseases treatment is expected to grow due to rising prevalence of musculoskeletal disorders, increasing elderly population, and technological advancements in musculoskeletal disease diagnosis are boosting the market over the years. In addition, the development of hybrid diagnostic systems are likely to have a positive impact on the growth of the market in the coming years.

Get PDF sample copy: http://bit.ly/2WQmcPa

The major players operating in the musculoskeletal diseases treatment market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi, Ltd., Accuray Incorporated, MR Solutions, Alltech Medical Systems, Terason Division Teratech Corporation, and Echo-Son SA. For instance, in September 2018, Royal Philips launched the Ingenia Ambition X 1.5T MR.

The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis. The developments performed by the companies are helping the market to grow in the coming years.

Arthritis Segment is expected to grow the Market for Musculoskeletal Diseases Treatment over the Forecast Period for Disease Segment.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. It is expected that major chunk of the demand is expected to generate from the above mentioned countries. Additionally, factors such as increasing focus of global industry players in India and Japan, funds in China are likely to propel growth of the market.

Buy the complete report @ http://bit.ly/2WQmk16

Strategic Insights

Product launch/update and agreements & partnerships were observed as the most adopted strategy in global musculoskeletal disease treatment industry. Few of the product approvals and partnerships made by the players in the market are listed below;

2018: In Spetember, Royal Philips launched the Ingenia Ambition X 1.5T MR. The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis.

2017: In November, Canon Medical Systems announced the launch of the new package for its iSeries scanners. The series will include Aplio i700, i800, and i900 which will be assessing the patients suffering from diseases.

2018: In January, AllTech Medical Systems America and RSTI signed an agreement to provide training. The agreement focusses RSTI offering an MRI service training program at Alltech Medical Systems America’s headquarters in Solon, Ohio. The program is to provide complete spectrum of service solutions and MRI training courses.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.